APO Research
Talk to an analyst

APO RESEARCH · REPORT

Primaquine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Primaquine Industry Growth and Trends Forecast to 2032

26 December 202577 pages

Choose your research edition.

Industry ResearchPrimaquine Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Primaquine Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Primaquine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Primaquine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Primaquine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Primaquine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Primaquine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Primaquine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Primaquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Primaquine include Cyper Pharma, Santa Cruz Biotechnology, Summit Medical Group and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Primaquine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Primaquine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Primaquine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Primaquine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Primaquine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Primaquine Market by Company

Cyper Pharma

Santa Cruz Biotechnology

Summit Medical Group

Pfizer

Primaquine Segment by Type

Injectables Primaquine

Tablets Primaquine

Capsules Primaquine

Primaquine Segment by Application

Laboratory

Hospital

Clinic

Others

Primaquine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primaquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Primaquine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primaquine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Primaquine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Primaquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injectables Primaquine Table 2. Major Company of Tablets Primaquine Table 3. Major Company of Capsules Primaquine Table 4. Global Primaquine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Primaquine Sales by Type (2021-2026) & (K Units) Table 6. Global Primaquine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Primaquine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Primaquine Sales Market Share in Value by Type (2021-2026) Table 9. Global Primaquine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Primaquine Sales by Type (2027-2032) & (K Units) Table 11. Global Primaquine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Primaquine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Primaquine Sales Market Share in Value by Type (2027-2032) Table 14. Global Primaquine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Primaquine Sales by Type (2021-2026) & (K Units) Table 16. North America Primaquine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Primaquine Sales by Type (2021-2026) & (K Units) Table 18. Europe Primaquine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Primaquine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Primaquine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Primaquine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Primaquine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Primaquine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Primaquine Sales by Type (2021-2026) & (US$ Million) Table 25. Primaquine Industry Trends Table 26. Primaquine Industry Drivers Table 27. Primaquine Industry Opportunities and Challenges Table 28. Primaquine Industry Restraints Table 29. Global Primaquine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Primaquine Revenue Market Share by Company (2021-2026) Table 31. Global Primaquine Sales by Company (2021-2026) & (K Units) Table 32. Global Primaquine Sales Share by Company (2021-2026) Table 33. Global Primaquine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Primaquine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Primaquine Major Company Production Sites and Headquarters Table 36. Global Primaquine Company, Product Type & Application Table 37. Global Primaquine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Primaquine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Primaquine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Primaquine Sales by Region (2021-2026) & (K Units) Table 42. Global Primaquine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Primaquine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Primaquine Sales Market Share in Value by Region (2021-2026) Table 45. Global Primaquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Primaquine Sales by Region (2027-2032) & (K Units) Table 47. Global Primaquine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Primaquine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Primaquine Sales Market Share in Value by Region (2027-2032) Table 50. Global Primaquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Primaquine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Primaquine Sales by Application (2021-2026) & (K Units) Table 53. Global Primaquine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Primaquine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Primaquine Sales Market Share in Value by Application (2021-2026) Table 56. Global Primaquine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Primaquine Sales by Application (2027-2032) & (K Units) Table 58. Global Primaquine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Primaquine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Primaquine Sales Market Share in Value by Application (2027-2032) Table 61. Global Primaquine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Primaquine Sales by Application (2021-2026) & (K Units) Table 63. North America Primaquine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Primaquine Sales by Application (2021-2026) & (K Units) Table 65. Europe Primaquine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Primaquine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Primaquine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Primaquine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Primaquine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Primaquine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Primaquine Sales by Application (2021-2026) & (US$ Million) Table 72. Cyper Pharma Company Information Table 73. Cyper Pharma Business Overview Table 74. Cyper Pharma Primaquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Cyper Pharma Primaquine Product Portfolio Table 76. Cyper Pharma Recent Development Table 77. Santa Cruz Biotechnology Company Information Table 78. Santa Cruz Biotechnology Business Overview Table 79. Santa Cruz Biotechnology Primaquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Santa Cruz Biotechnology Primaquine Product Portfolio Table 81. Santa Cruz Biotechnology Recent Development Table 82. Summit Medical Group Company Information Table 83. Summit Medical Group Business Overview Table 84. Summit Medical Group Primaquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Summit Medical Group Primaquine Product Portfolio Table 86. Summit Medical Group Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Primaquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Primaquine Product Portfolio Table 91. Pfizer Recent Development Table 92. North America Primaquine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. North America Primaquine Sales by Country (2021-2026) & (K Units) Table 94. North America Primaquine Sales Market Share by Country (2021-2026) Table 95. North America Primaquine Sales Forecast by Country (2027-2032) & (K Units) Table 96. North America Primaquine Sales Market Share Forecast by Country (2027-2032) Table 97. North America Primaquine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America Primaquine Market Size by Country (2021-2026) & (US$ Million) Table 99. North America Primaquine Market Share by Country (2021-2026) Table 100. North America Primaquine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America Primaquine Market Share Forecast by Country (2027-2032) Table 102. Europe Primaquine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Europe Primaquine Sales by Country (2021-2026) & (K Units) Table 104. Europe Primaquine Sales Market Share by Country (2021-2026) Table 105. Europe Primaquine Sales Forecast by Country (2027-2032) & (K Units) Table 106. Europe Primaquine Sales Market Share Forecast by Country (2027-2032) Table 107. Europe Primaquine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe Primaquine Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe Primaquine Market Share by Country (2021-2026) Table 110. Europe Primaquine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe Primaquine Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Primaquine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Primaquine Sales by Country (2021-2026) & (K Units) Table 114. Asia-Pacific Primaquine Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific Primaquine Sales Forecast by Country (2027-2032) & (K Units) Table 116. Asia-Pacific Primaquine Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Primaquine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Primaquine Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific Primaquine Market Share by Country (2021-2026) Table 120. Asia-Pacific Primaquine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific Primaquine Market Share Forecast by Country (2027-2032) Table 122. Latin America Primaquine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Latin America Primaquine Sales by Country (2021-2026) & (K Units) Table 124. Latin America Primaquine Sales Market Share by Country (2021-2026) Table 125. Latin America Primaquine Sales Forecast by Country (2027-2032) & (K Units) Table 126. Latin America Primaquine Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America Primaquine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America Primaquine Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America Primaquine Market Share by Country (2021-2026) Table 130. Latin America Primaquine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America Primaquine Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Primaquine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Primaquine Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Primaquine Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa Primaquine Sales Forecast by Country (2027-2032) & (K Units) Table 136. Middle East and Africa Primaquine Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Primaquine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Primaquine Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa Primaquine Market Share by Country (2021-2026) Table 140. Middle East and Africa Primaquine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa Primaquine Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Primaquine Distributors List Table 145. Primaquine Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Primaquine Image Figure 2. Global Primaquine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Primaquine Market Size (2021-2032) & (US$ Million) Figure 4. Global Primaquine Sales (2021-2032) & (K Units) Figure 5. Injectables Primaquine Image Figure 6. Global Injectables Primaquine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablets Primaquine Image Figure 8. Global Tablets Primaquine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Capsules Primaquine Image Figure 10. Global Capsules Primaquine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Primaquine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Primaquine Market Share by Type 2025 VS 2032 Figure 13. North America Primaquine Sales Market Share in Volume by Type in 2025 Figure 14. North America Primaquine Sales Market Share in Value by Type in 2025 Figure 15. Europe Primaquine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Primaquine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Primaquine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Primaquine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Primaquine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Primaquine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Primaquine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Primaquine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Primaquine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Laboratory Image Figure 26. Global Laboratory Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Primaquine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Primaquine Market Share by Application 2025 VS 2032 Figure 35. North America Primaquine Sales Market Share in Volume by Application in 2025 Figure 36. North America Primaquine Sales Market Share in Value by Application in 2025 Figure 37. Europe Primaquine Sales Market Share in Volume by Application in 2025 Figure 38. Europe Primaquine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Primaquine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Primaquine Sales Market Share in Value by Application in 2025 Figure 41. Latin America Primaquine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Primaquine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Primaquine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Primaquine Sales Market Share in Value by Application in 2025 Figure 45. North America Primaquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Primaquine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Primaquine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Primaquine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Primaquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Primaquine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Primaquine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Primaquine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Primaquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Primaquine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Primaquine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Primaquine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Primaquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Primaquine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Primaquine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Primaquine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Primaquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Primaquine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Primaquine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Primaquine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Primaquine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Primaquine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injectables Primaquine
  • Tablets Primaquine
  • Capsules Primaquine
Applications
  • Laboratory
  • Hospital
  • Clinic
  • Others
Companies covered
  • Cyper Pharma
  • Santa Cruz Biotechnology
  • Summit Medical Group
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Primaquine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Primaquine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Primaquine Market by Type
  6. 1.3.1 Injectables Primaquine
  7. 1.3.2 Tablets Primaquine
  8. 1.3.3 Capsules Primaquine
  9. 1.4 Global Primaquine Market Size by Type
  10. 1.4.1 Global Primaquine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Primaquine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Primaquine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Primaquine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Primaquine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Primaquine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Primaquine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Primaquine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Primaquine Industry Trends
  2. 2.2 Primaquine Industry Drivers
  3. 2.3 Primaquine Industry Opportunities and Challenges
  4. 2.4 Primaquine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Primaquine Revenue (2021-2026)
  2. 3.2 Global Top Players by Primaquine Sales (2021-2026)
  3. 3.3 Global Top Players by Primaquine Price (2021-2026)
  4. 3.4 Global Primaquine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Primaquine Major Company Production Sites & Headquarters
  6. 3.6 Global Primaquine Company, Product Type & Application
  7. 3.7 Global Primaquine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Primaquine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Primaquine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Primaquine Tier 1, Tier 2, and Tier 3
4 Primaquine Regional Status and Outlook
  1. 4.1 Global Primaquine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Primaquine Historic Market Size by Region
  3. 4.2.1 Global Primaquine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Primaquine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Primaquine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Primaquine Forecasted Market Size by Region
  7. 4.3.1 Global Primaquine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Primaquine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Primaquine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Primaquine by Application
  1. 5.1 Primaquine Market by Application
  2. 5.1.1 Laboratory
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.1.4 Others
  6. 5.2 Global Primaquine Market Size by Application
  7. 5.2.1 Global Primaquine Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Primaquine Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Primaquine Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Primaquine Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Primaquine Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Primaquine Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Primaquine Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Primaquine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cyper Pharma
  2. 6.1.1 Cyper Pharma Company Information
  3. 6.1.2 Cyper Pharma Business Overview
  4. 6.1.3 Cyper Pharma Primaquine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cyper Pharma Primaquine Product Portfolio
  6. 6.1.5 Cyper Pharma Recent Developments
  7. 6.2 Santa Cruz Biotechnology
  8. 6.2.1 Santa Cruz Biotechnology Company Information
  9. 6.2.2 Santa Cruz Biotechnology Business Overview
  10. 6.2.3 Santa Cruz Biotechnology Primaquine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Santa Cruz Biotechnology Primaquine Product Portfolio
  12. 6.2.5 Santa Cruz Biotechnology Recent Developments
  13. 6.3 Summit Medical Group
  14. 6.3.1 Summit Medical Group Company Information
  15. 6.3.2 Summit Medical Group Business Overview
  16. 6.3.3 Summit Medical Group Primaquine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Summit Medical Group Primaquine Product Portfolio
  18. 6.3.5 Summit Medical Group Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Primaquine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Primaquine Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
7 North America by Country
  1. 7.1 North America Primaquine Sales by Country
  2. 7.1.1 North America Primaquine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Primaquine Sales by Country (2021-2026)
  4. 7.1.3 North America Primaquine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Primaquine Market Size by Country
  6. 7.2.1 North America Primaquine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Primaquine Market Size by Country (2021-2026)
  8. 7.2.3 North America Primaquine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Primaquine Sales by Country
  2. 8.1.1 Europe Primaquine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Primaquine Sales by Country (2021-2026)
  4. 8.1.3 Europe Primaquine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Primaquine Market Size by Country
  6. 8.2.1 Europe Primaquine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Primaquine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Primaquine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Primaquine Sales by Country
  2. 9.1.1 Asia-Pacific Primaquine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Primaquine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Primaquine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Primaquine Market Size by Country
  6. 9.2.1 Asia-Pacific Primaquine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Primaquine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Primaquine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Primaquine Sales by Country
  2. 10.1.1 South America Primaquine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Primaquine Sales by Country (2021-2026)
  4. 10.1.3 South America Primaquine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Primaquine Market Size by Country
  6. 10.2.1 South America Primaquine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Primaquine Market Size by Country (2021-2026)
  8. 10.2.3 South America Primaquine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Primaquine Sales by Country
  2. 11.1.1 Middle East and Africa Primaquine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Primaquine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Primaquine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Primaquine Market Size by Country
  6. 11.2.1 Middle East and Africa Primaquine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Primaquine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Primaquine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Primaquine Value Chain Analysis
  2. 12.1.1 Primaquine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Primaquine Production Mode & Process
  7. 12.2 Primaquine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Primaquine Distributors
  10. 12.2.3 Primaquine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst